Cytoplasmic Inclusion Bodies in Escherichia coli Producing Biosynthetic Human Insulin Proteins
- 5 February 1982
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 215 (4533) , 687-689
- https://doi.org/10.1126/science.7036343
Abstract
Escherichia coli that has been genetically manipulated by recombinant DNA technology to synthesize human insulin polypeptides (A chain, B chain, or proinsulin) contains prominent cytoplasmic inclusion bodies. The amount of inclusion product within the cells corresponds to the quantity of chimeric protein formed by the bacteria. At peak production, the inclusion bodies may occupy as much as 20 percent of the Escherichia coli cellular volume.This publication has 8 references indexed in Scilit:
- The Role of Electron Microscopy in the Elucidation of Bacterial Structure and FunctionAnnual Review of Microbiology, 1979
- Chemical synthesis of genes for human insulin.Proceedings of the National Academy of Sciences, 1978
- Degradation of abnormal proteins in Escherichia coli. Formation of protein inclusions in cells exposed to amino acid analogs.Journal of Biological Chemistry, 1975
- Inclusion Bodies of ProkaryotesAnnual Review of Microbiology, 1974
- Isolation and morphology of native intracellular polyglucose granules from Clostridium pasteurianumCanadian Journal of Microbiology, 1973
- Amino Acid Antagonist Death in Escherichia coliJournal of Bacteriology, 1969
- Mechanism of canavanine death in Escherichia coliJournal of Molecular Biology, 1968
- ELECTRON MICROSCOPY OF POLYRIBOSOMES WITHIN BACILLUS CEREUSJournal of Bacteriology, 1964